Cerebral metastasis of cervical uterine cancer: report of three cases

Metástases cerebrais de câncer de colo de útero: relato de três casos

Cerebral metastasis of cervical uterine cancer: report of three cases

Metástases cerebrais de câncer de colo de útero: relato de três casos

Joacir Graciolli Cordeiro^I; Daniel Monte-Serrat Prevedello^II; Léo Fernando da Silva Ditzel^II; Carlos Umberto Pereira^III; João Cândido Araújo^IV

Department of Neurosurgery, Hospital Nossa Senhora das Graças, Curitiba PR, Brazil

^IResident in Neurosurgery

^IINeurosurgeon

^IIINeurosurgeon, Federal University of Sergipe (Aracaju SE, Brasil)

^IVNeurosurgeon Director of the Residency Program

ABSTRACT

Cervical uterine cancer (CUC) spreads locally (pelvis and paraortic lymphnodes) or distantly (lungs, liver and bones). Metastasis to central nervous system (CNS) are rare. There are about 80 cases reported in the literature. Outcome is poor and survival varies from 3 to 6 months. Three cases of CNS metastasis from CUC are reported, one infratentorial and two supratentorials in location. In one patient, the initial manifestation was due to the cerebral lesion, a feature reported for the first time. All cases were treated by surgery, radiotherapy and/or chemotherapy. Clinical findings and treatment options of these rare lesions are reviewed.

Key words: cerebral metastasis, cervical uterine cancer.

RESUMO

Tumores do cólo uterino se disseminam por contigüidade ou via hematogênica (pulmão, fígado e ossos). Metástases para sistema nervoso central são incomuns. Apenas cerca de 80 casos são citados na literatura. Manifestações clínicas são devidas à hipertensão intracraniana e a déficits focais. A sobrevida varia de 3 a 6 meses. Três casos são relatados sendo um infratentorial e dois supratentoriais. No primeiro, o diagnóstico da metástase antecedeu o da lesão uterina. No segundo, houve 5 anos sem recidiva após a cirurgia, fato este inédito. O tratamento foi cirurgia, radioterapia e/ou quimioterapia. A discussão enfatiza manejo multidisciplinar destas raras lesões.

Palavras-chave: metástase cerebral, câncer de colo uterino.

Cervical uterine cancer (CUC) is responsible for 15% of deaths due to cancer in women older than 15 years of age in Brazil¹. It most often invades local structures, reaching pelvis and paraortic lymphnodes. Distant organs are reached by haematogenous dissemination^1-4. The frequency of distant organs metastasis varies from 38 to 85%^5-7. Haematogenous spread is responsible for a more aggressive behaviour. Most commonly affected distant organs are lungs, liver and bones⁶. Brain involvement is extremely rare^1-24. There are reports of cervical cancer metastasis to pituitary gland, pancreas, urether, kidney, adrenal gland, ovaries, uterine tube, gallbladder, spine cord and to a convexity brain meningioma^{5,10,18,21,24}.

The objective of this article is to report three cases of cerebral metastasis from cervical uterine cancer and to discuss their clinical features and treatment options.

This study was performed with the approval of the Ethics Committee of the hospitals where these three patients were treated. Informed consent was obtained from either the patient or a relative in all cases.

CASES

Case 1 – A 60-year-old woman was admitted with a scalp lesion, history of local trauma and antibiotic therapy without improvement 30 days before admission. She had no other complaints. Physical examination revealed only an ulcerated left parietal-occipital scalp lesion. Skull X-ray demonstrated an osteolytic pattern. CT scan revealed a hypodense right parietal-occipital cerebral lesion with ring enhancement and perilesional edema. The lesion was surgically removed and pathological diagnosis was that of a metastatic adenocarcinoma. Systemic screening revealed CUC II B clinical stage. She did not return for follow-up.

Case 2 – A 31-year-old woman was admitted with headache and visual deficit since 2 weeks before admission. She had been submitted to lung metastasis resection from CUC 10 months before admission in another service. She received adjuvant chemotherapy and local radiotherapy. On physical examination she presented right homonymous hemianopsia. Cranial MRI revealed a 3 cm diameter left occipital lesion with ring enhancement, perilesional edema and central hypointensity in T1 and hyperintensity in T2-weighted images (Fig 1). The lesion was completely removed by craniotomy and pathological diagnosis was that of low differentiated carcinoma similar to her cervical uterine cancer. She received adjuvant whole brain radiotherapy. Postoperative period was unremarkable and she presented no other deficits. She had no recurrence of the lesion and no other neurological manifestation in 5 years of follow-up (Fig 2).

Case 3 – A 31-year-old woman was admitted with headache, drowsiness, vomiting, visual impairment and diplopia since 2 months before admission. Two years earlier she had been submitted to pan-hysterectomy for mucinous cervical uterine adenocarcinoma. She received adjuvant brachytherapy and teletherapy. On physical examination she presented with disorientation, right dismetria ant gait ataxia. CT scan revealed a right hemispheric cerebellar heterogeneous lesion and supratentorial hydrocephalus. MRI showed a 5 cm diameter lesion isointense in T1-weighted images and irregular contrast enhancement. She was submitted to ventricular drainage and lesion removal through a suboccipital craniectomy. Specimen was compatible with low differentiated adenocarcinoma similar to her cervical uterine cancer. She received adjuvant whole brain radiotherapy. Post-operatively she developed pneumonia and urinary tract infection. Abdominal ultrasound revealed local invasive recurrence. She died one month latter due to complications of urinary tract infection.

DISCUSSION

Cerebral metastasis from cervical uterine cancer were reported initially by Henriksen in 1949. They appear late in the clinical course of this disease¹⁰. Their occurrence is very uncommon. There are about 80 cases reported in literature, with brain involvement usually occurring late in the course of the disease, usually preceeded by local pelvic invasion^1-24.

Haematogenous spread depends on histological type of the tumor. Cerebral metastasis are more frequent in poorly differentiated tumors. Histological subtypes in decreasing frequency are squamous cells carcinoma, adenocarcinoma, carcinoid tumor and adenosquamous carcinoma^3,4,16. Cases in present report comprise one squamous cell carcinoma and two adenocarcinomas.

Accordding to Kishi, most common clinical presentation include headache (34%), hemiparesis (25.8%), confusion (22.7%), monoparesis (14.4%) and nausea (9.2%)¹⁷. In Robinson's review, most common initial symptoms were hemiparesis, headache, facial palsy and seizures. Ikeda related a medium interval between initial diagnosis and brain metastasis of 28 months¹⁶. Case 1 had no previous neurological or systemic manifestations and represents the only reported case in which diagnosis was initially made out of a metastatic brain and scalp lesion^1-24. Case 2 is free from the disease 5 years after diagnosis and surgery. To our knowledge this is the first reported case with such a long survival in literature^1-24.

CUC brain metastasis are solitary in one third of the patients and frontal lobe is the most common affected site^{3,9,11,13,14,18,22}. In Ikeda's review, 50% were solitary lesions and all of them were supratentorial.¹⁶. Cormio reported 6 single lesions, 8 multiple, 10 supratentorial, 2 cerebellar and 2 with infra and supratentorial involvement^2,12. As opposed to the literature, our 3 cases were solitary lesions and none in frontal lobe.

CUC brain metastasis are usually treated by surgery, chemotherapy and radiotherapy. Surgical removal is a consensus in the literature for solitary lesions^4,19,20. Surgery may also be considered in case of two or more lesions surgically removable in the same craniotomy²³. Other surgical indications are lack of diagnosis, life threatening situations (hemorrhage, hydrocephalus or infection), symptomatic relief after ineffective clinical treatment and insertion of intrathecal chemotherapy devices²³.

Radiotherapy may play an adjuvant role to surgical resection or remains as the only local treatment, associated or not to chemotherapy. Patchell revealed that patients treated with surgery plus radiotherapy had longer survival, better neurological condition and lower recurrence of the disease in the nervous system, when compared to those who received radiotherapy alone¹⁹. Most of the authors consider surgery followed by adjuvant radiotherapy the best option for solitary CUC brain metastasis^{5,6,10,12,16,18,21}.

Stereotaxic radiosurgery is as effective as conventional surgery for local brain metastasis control and may also be used in inaccessible lesions⁸. There are no data in literature about radiosurgery effects in CUC brain metastasis. The decision between conventional craniotomy plus adjuvant radiotherapy and radiosurgery must be made on an individual basis, considering size, number and location of the lesion, clinical condition and available technology^{4,5,6,8,16,20,23}.

Chemotherapy plays an important role in clinical treatment of CUC and cisplatin is the most frequently used drug. Chemotherapy may determine regression of CUC brain metastasis and also has systemic effect. Its final influence in the outcome of CUC cerebral metastasis is still unknown^2,3,6,12. In cases with multiple lesions, chemotherapy may be the first choice of treatment^{5,6,10,12,16,18,21}. Cases 2 and 3 developed brain metastasis despite adjuvant chemotherapy for uterine disease.

Other therapeutic suggested strategies in study for clinical treatment of unresecable metastasis include selective intra-arterial chemotherapy, use of reversible haemato-encephalic barrier modifiers and hormonal therapy (melatonin) without, however, worthwhile effect². Outcome of patients with CUC brain metastasis depends on age, neurological status, length of clinical history, histological subtypes, number of lesions and clinical comorbidities. The prognosis is poor despite any treatment option, with survival of 3 to 6 months after diagnosis of brain metastasis¹⁰.

Received 7 June 2005, received in final form 16 January 2006. Accepted 23 January 2006.

Dr. Joacir Graciolli Cordeiro - Rua Alcides Munhoz 433 - Neurocirurgia - 80810-040 Curitiba PR - Brasil. E-mail: [e-mail]

• 1. Urbanetz AA, Hatchback SBB, Oliveira LJ. Câncer de colo uterino. In: Urbanetz AA, et al (eds). Ginecologia obstetrícia reprodução humana. Curitiba: Relisul, 1992:169-170.
• 2. Cormio G, Pellegrino A, Landoni F, et al. Brain metastasis from cervical carcinoma. Tumori 1996;82:394-396.
• 3. Kumar L, Tanwar RK, Singh SP. Intracranial metastasis from carcinoma cervix and review of literature. Gynecol Oncol 1992;46:391-392.
• 4. Robinson JB, Morris M. Cervical carcinoma metastatic to the brain. Gynecol Oncol 1997;66:324-326.
• 5. Carlson V, Delclos L, Fletcher GH. Distant metastasis in squamous-cell carcinoma of the uterine cervix. Radiology 1967;88:961-966.
• 6. Hanel RA, Suzuki NC, Ogata AC, Soares EW. Carcinoma de colo de útero com possíveis metástases cerebrais: relato de um caso incomum. Acta Oncol Bras 1995;15:81-83.
• 7. Holzaepfel JH, Ezell HE. Sites of metastasis of uterine carcinoma. Am J Obstet Gynecol 1955;69:1027-1038.
• 8. Alexander E III, Marioarty TM, Davis RB, et al. Stereotatic radiosurgery for the definitive, non-invasive treatment of brain metastasis. J Natl Cancer Inst 1995;87:34-40.
• 9. Andrew J. Cerebral metastasis from cervical carcinoma. J Obstet Gynecol Br Emp 1953;60:545-549.
• 10. Badib AO, Kurohara SS, Webster JH, Pickren JW. Metastasis to organs in carcinoma of uterine cervix: influence of treatment on incidence and distribution. Cancer 1968;21:434-439.
• 11. Buchsbaum HJ, Rice AC. Cerebral metastasis in cervical carcinoma. Am J Obstet Gynecol 1972;114:276-278.
• 12. Cormio G, Colamaria A, Loverro G, et al. Surgical resection of a cerebral metastasis from cervical cancer: case report and review of literature. Tumori 1999;85:65-67.
• 13. Friedman M, Nissenbaum M, Lakier R, Browde S. Brain metastasis in early cancer of uterine cervix. South Afr Med J 1983;64:488-489.
• 14. Gill TJ, Dammin GJ. A case of epidermoid carcinoma of the cervix uteri with cerebral metastasis. J Pathol Bacteriol 1959;78:569-571.
• 15. Henriksen E. The lymphatic spread of carcinoma of the cervix and of the body of the uterus. Am J Obstet Gynecol 1949;58:924-942.
• 16. Ikeda S, Yamada T, Katsumata N, et al. Cerebral metastasis in patients with uterine cervical cancer. Jpn J Clin Oncol 1998;28:27-29.
• 17. Kishi K, Nomura K, Miki Y, Shibuis, Takakura K. Metastatic brain tumor: a clinical and pathologic analysis of 101 cases with biopsy. Arch Pathol Lab Med 1982;106:133-135.
• 18. Lefkowitz D, Asconape J, Biller J. Intracranial metastasis from carcinoma of cervix. South Med J 1983;76:519-521.
• 19. Patchell RA, Tibbs PA, Walsh JW. A randomised trial in the surgery of treatment of single metastasis to the brain. N Engl J Med 1990;332: 494-500
• 20. Posner JB, Chernik NL. Intracranial metastasis from systemic cancer. Adv Neurol 1978;19:579-591.
• 21. Salpietro FM, Romano A, Alafaci C, Tomasello F. Pituitary metastasis from uterine cervical carcinoma: a case presenting as diabetes insipidus. Brit J Neurosurg 1998;14:156-159.
• 22. Vieth RG, Odom GL. Intracranial metastasis and their neurosurgical treatment. J Neurosurg 1965;23:375-383.
• 23. Wright DC, Delaney TF, Buckner JC. Treatment of metastatic cancer to the brain. In De Vita VT Jr, Hellman S, Rosemberg AS (eds). Cancer: principles and practice of oncology. Philadelphia: Lippincott 1993:2170-2186.
• 24. Wu WQ, Hiszezynskyj R. Metastastasis of carcinoma of cervix uteri to convexity meningioma. Surg Neurol 1977:327-329.

Publication Dates

• Publication in this collection
  08 June 2006
• Date of issue
  June 2006

History

• Accepted
  23 Jan 2006
• Reviewed
  16 Jan 2006
• Received
  07 June 2005